Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
52W High
$14.20
52W Low
$2.64
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
-0.73
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
0.56
Forward P/E (<15 better)
117.65
EV/EBITDA (<8 favorable)
-3.24
EV/Revenue (<3 favorable)
2.23
P/S (TTM) (<3 favorable)
2.92
P/B (<3 favorable)
3.22
Ownership
BalancedSource: Overview
Insiders (1–5% typical)
14.19%
Institutions (25–75% balanced)
26.46%
Shares Outstanding
14,650,400
Float
12,570,300
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
2014-04-28
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
16,886,400
Gross Profit (TTM)
5,854,000
EPS (TTM)
6.00
Profit Margin (>10% good)
-1.94%
Operating Margin (TTM) (higher better)
-2.27%
ROE (TTM) (>15% strong)
-1.06%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.18
Momentum
Bearish momentumValue
-0.2258
Previous
-0.2386
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025